
Journal of the American Chemical Society p. 17738 - 17749 (2014)
Update date:2022-08-04
Topics: Regioselectivity Diastereoselectivity Yield NMR spectroscopy Total synthesis Enantioselective synthesis HPLC (high-performance liquid chromatography) Protecting group Ligand Design Asymmetric Induction Chiral Resolution Substrate Scope Chiral Catalyst Catalytic Cycle C-H Functionalization Oxidative Coupling Mechanistic study Stereocenter
Lu, Ping
Mailyan, Artur
Gu, Zhenhua
Guptill, David M.
Wang, Hengbin
Davies, Huw M. L.
Zakarian, Armen
The evolution of a program directed at the enantioselective total synthesis of maoecrystal V, a highly modified ent-kauranoid, is described. An early stage chiral auxiliary-directed asymmetric C-H functionalization for the construction of a key benzofuran intermediate enabled the first asymmetric synthesis of the natural enantiomer of maoecrystal V, confirming the assigned stereochemistry. A divergent course of the central intramolecular Diels-Alder reaction, which is dependent on the nature of the dienophile, initially led to the development of an unanticipated and previously unknown isomer of maoecrystal V, which we named maoecrystal ZG. In light of the reported selective and potent cytotoxic activity of maoecrystal V, the cytotoxic properties of maoecrystal ZG were also investigated.
View MoreZhengzhou Yuanli Biological Technology Co., Ltd.
Contact:+86-371-67897870/67897895
Address:No. 38, Qingyang Street, Zhengzhou, Henan, China
Contact:13813902930 025-52714267
Address:20 Fengji Road, Yuhua Economic Development Zone, Nanjing, Jiangsu, P. R. China
website:http://www.acrospharmatech.com
Contact:+1-3234804688
Address:Flat/RM 1502,Easey Commercial building 253-261 Hennessy Road,Wanchai,HongKong
shijiazhuang alkay chemicals co..ltd(expird)
Contact:86-311-67692035
Address:2601,juntang building,qiaodong district,shijiazhuang
Anhui Redstar Pharmaceutical Corp., Ltd
Contact:+86-563-5120837
Address:Jingxian Industrial Development Zone, Anhui , China
Doi:10.1002/(SICI)1097-458X(199803)36:3<205::AID-OMR237>3.0.CO;2-L
(1998)Doi:10.1016/S0040-4020(01)88303-4
(1992)Doi:10.1021/ol4009206
(2013)Doi:10.1021/ol401062z
(2013)Doi:10.2478/s11696-013-0313-0
(2013)Doi:10.1002/adsc.201500905
(2016)